Healthcare -
Biotechnology - NASDAQ - US
$ 1.325
-3.28 %
$ 375 M
Market Cap
-1.68
P/E
ERAS - TOTAL EQUITY
Total Equity ERAS - Erasca, Inc.
317 M
LAST VALUE
82.47%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR